| Sonja Tuel, PA-C | |
|
943 N Andover Rd, Andover, KS 67002-9795 | |
| (316) 733-4747 | |
| Not Available |
| Full Name | Sonja Tuel |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 943 N Andover Rd, Andover, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467721738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Via Christi Hospital-wichita | Wichita, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gracemed Health Clinic Inc | 9830098185 | 31 |
News Archive
The therapeutic use of human cell and tissue products is highly regulated by the U.S. government, but a specific exception allows surgeons to harvest, manipulate, and implant tissues in many commonly performed procedures.
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL).
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a unanimous vote of 12 to 0 that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, be granted marketing approval by the FDA for the treatment of Dupuytren's contracture.
A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio.
About 25,000 Danes currently live with congenital heart defects. Both heredity and environment play a role for these malformations, but exactly how various risk factors influence the development of the heart during pregnancy has been a mystery until now.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sonja Tuel, PA-C 9390e Central Ave 101, Wichita, KS 67206-2565 Ph: (316) 682-5591 | Sonja Tuel, PA-C 943 N Andover Rd, Andover, KS 67002-9795 Ph: (316) 733-4747 |
News Archive
The therapeutic use of human cell and tissue products is highly regulated by the U.S. government, but a specific exception allows surgeons to harvest, manipulate, and implant tissues in many commonly performed procedures.
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL).
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a unanimous vote of 12 to 0 that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, be granted marketing approval by the FDA for the treatment of Dupuytren's contracture.
A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio.
About 25,000 Danes currently live with congenital heart defects. Both heredity and environment play a role for these malformations, but exactly how various risk factors influence the development of the heart during pregnancy has been a mystery until now.
› Verified 8 days ago
Christopher Ryan Lemons, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-993-1774 | |
Emi Hayashi, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1118 E Us Highway 54, Andover, KS 67002 Phone: 316-655-7311 | |
Jill L Johnson-smith, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 612 N Andover Rd, Andover, KS 67002 Phone: 316-733-6618 Fax: 316-733-5299 | |
Mrs. Shala Renee Holman, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1124 W. 21st Street, Andover, KS 67002 Phone: 316-300-4000 Fax: 316-300-4040 | |
Jamie Marie Geier, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-733-1331 Fax: 316-677-2747 | |
Mrs. Rachel Ann Ewing, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 105 S Andover Rd, Suite D, Andover, KS 67002 Phone: 316-733-5120 Fax: 316-733-1280 | |
Mckay Alexander Brumfield, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1731 N Basswood Ct, Andover, KS 67002 Phone: 316-573-3504 |